BD Q4 revenue $5.9B (+8.3%); FY25 adjusted EPS $14.40 (+9.6%); FY26 guidance

BECTON DICKINSON & CO

2025-FY EPS reported $5.82 vs consensus $2.84 ▲ beat (+104.9%)

Q4 revenue $5,890M, up 8.3% as reported, 3.9% organic; GAAP EPS $1.72, adjusted EPS $3.96.
FY25 revenue $21.8B (+8.2% as reported); GAAP EPS $5.82 (-0.7%), adjusted EPS $14.40 (+9.6%).
FY25 adjusted operating margin up 80 bps to 25.0%; adjusted gross margin up 140 bps.
Returned $2.2B to shareholders in FY25 via dividends and share repurchases.
Biosciences/Diagnostic Solutions combination with Waters Corp on track to close near end of Q1 CY2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.